Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Waterman Capital Wins NZVCA 2015 Deal of the Year Award

MEDIA RELEASE

23 October 2015

Waterman Capital Wins NZVCA 2015 Deal of the Year Award

The 2015 New Zealand Private Equity and Venture Capital Association (NZVCA) Deal of the Year Award has gone to Waterman Capital for its investment in Manuka Health.

The NZVCA Deal of the Year Award recognises outstanding performance in the private equity industry and was announced at the NZVCA 2015 annual conference in Queenstown yesterday (22 October).

NZVCA Executive Director Colin McKinnon says: `The Waterman Capital investment in Manuka Health is an example of innovation, growth, and excellent returns on investment that benefit investors. Through the period of Waterman’s ownership revenue grew from $17m in 2012 to approximately $70m in the current year.’

Entries were judged on return to investors and the company's financial performance. The company's contribution to the economy, employment, innovation, consistency and industry competitiveness was also taken into account.

Mr McKinnon adds: ‘the winner of our 2015 award is an example of the purpose and aim of private equity: to partner with companies to improve growth and performance, to share expertise and capital. This ultimately delivers improved productivity, creates jobs and contributes to the national economy.’

Manuka Health is the second largest producer and exporter of Manuka honey related products in New Zealand and has demonstrated extraordinary year on year growth since its inception in 2006.

Waterman invested in Manuka Health in 2012 providing expansion capital to fund a number of growth initiatives. During this period the company:

• constructed a $10m, state of the art, processing facility in Te Awamutu which tripled production capabilities;

• quadrupled staff numbers including a number of senior appointments;

• made significant advancements to secure further supply of the key raw ingredients, manuka and propolis;

• invested significantly in research and development to support products with scientific health claims and protect relevant intellectual property; and,

• played a central role in introducing industry regulation which will benefit Manuka Health and the wider honey sector.

Established in 2004, Waterman Capital is one of New Zealand’s most experienced private equity players. It manages a series of funds that channel capital and skills to private companies like Manuka Health. Other investments include New Zealand’s largest education business Academic Colleges Group, and Healthcare Holdings (Mercy Ascot), operator of the largest private hospitals in Auckland.

ENDS


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Māui And Hector’s Dolphins: WWF/Industry Counter Offer On Threat Management Plan

Forest & Bird says WWF-NZ's plan for protecting Māui dolphins is based on testing unproven methods on a species that is almost extinct, and is urging the Government to reject the proposal. More>>

ALSO:

Industry Report: Growing Interactive Sector Wants Screen Grants

Introducing a coordinated plan that invests in emerging talent and allows interactive media to access existing screen industry programmes would create hundreds of hi-tech and creative industry jobs. More>>

ALSO:

Ground Rules: Government Moves To Protect Best Growing Land

“Continuing to grow food in the volumes and quality we have come to expect depends on the availability of land and the quality of the soil. Once productive land is built on, we can’t use it for food production, which is why we need to act now.” More>>

ALSO:

Royal Society: Calls For Overhaul Of Gene-Technology Regulations

An expert panel considering the implications of new technologies that allow much more controlled and precise ‘editing’ of genes, has concluded it’s time for an overhaul of the regulations and that there’s an urgent need for wide discussion and debate about gene editing... More>>

ALSO: